Print Print    Close Close

French prosecutors open probe into fatal drug trial

Published June 14, 2016

Reuters
France_drug_trial

FILE - This Friday, Jan. 15, 2016 file photo shows a logo of the Biotrial laboratory displayed on its building in Rennes, western France. France’s health minister has presented a plan to tighten up the rules regarding human drug trials following an experimental test that killed a volunteer in January. (AP Photo/David Vincent, File)

Paris prosecutors said on Tuesday they have begun an involuntary manslaughter investigation into a failed drug trial that left one dead and five hospitalized in January.

The prosecutors' office said the investigation had been opened to determine whether there was a criminal element in any mistakes made or whether it was simply the result of clinical risks involved.

France's Health Ministry said last month that Portuguese drugmaker Bial and French laboratory Biotrial were at fault "on several counts" for the drug trial.

More on this...

  • France to tighten up drug trial rules after fatal incident
  • France says Bial, Biotrial partly liable for fatal drug trial
  • France says results of trials in Guinea of anti-Ebola drug encouraging

Participants in the phase I trial were given the experimental drug made by Bial at a private facility in the city of Rennes run by France's Biotrial.

All trials of the drug, designed to treat mood and anxiety issues as well as coordination disorders linked to neurological issues, have been suspended.

Print Print    Close Close

URL

https://www.foxnews.com/health/french-prosecutors-open-probe-into-fatal-drug-trial

  • Home
  • Video
  • Politics
  • U.S.
  • Opinion
  • Entertainment
  • Tech
  • Science
  • Health
  • Travel
  • Lifestyle
  • World
  • Sports
  • Weather
  • Privacy
  • Terms

This material may not be published, broadcast, rewritten, or redistributed. © FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by LSEG. Do Not Sell my Personal Information - New Terms of Use - FAQ